• |
  • |
  • |
  • |
Donate

Project

Randomized, double-blind, paralle group, placebo controlled 28-day study to investigate the safety, toerability and pharmacodynamics of SB-656933 in p

Center:
Fiscal Year:
2011
Contact Information:
Project Description:
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
Regional
Funding Source:
COVID-19 Related Data:
N/A